Pfizer Senior Manager HEOR in New York City, New York
Patient Health Impact (PHI) offers solutions that help patients and health care providers manage chronic, costly conditions, and improve outcomes and overall health. Two key entities within PHI are the Health Economics and Outcomes Research (HEOR) and Payer Insights & Access (PI&A) groups. Both groups collaborate to achieve commercial success by designing and executing strategies that generate evidentiary data that resonate with patients (and their caregivers), payors, healthcare providers and policy-makers to obtain and maintain market access, as well as to increase market uptake.
The Senior Manager will be responsible for assisting in the generation, updating, refinement, and dissemination of robust and relevant HEOR material that supports the value of oncology products. The execution of this position will be conducted in close collaboration with the Director, HEOR and HEOR Team Leader as well as Global internal stakeholders, countries, functions within PHI, and other cross-functional teams. In addition, this position will function with a One PHI mindset and will work in a closely aligned fashion with Cross-Functional Leadership Team (CFLT) members to ensure there is a single and coordinated view on strategy and delivery for PHI to the oncology business. This position resides within the PHI HEOR group, reporting to the HEOR Hematology and RCC Team Lead.
Lead the development of Health Economics and Outcomes Research (HEOR) strategy to support the value of assets in the Oncology Business Unit (BU) in close partnership with the Cross-Functional Leadership Team (CFLT) members.
Develop real world evidence generation strategies and flawlessly execute studies (e.g., burden of illness studies, epidemiology studies, etc).
Lead the execution of HEOR studies and projects (including Non-Interventional Studies, registries, etc) in alignment with the global O&E strategy and demonstrate the value proposition for assets in the Oncology BU.
Incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy for the assets and to ensure global reimbursement and access requirements. Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
Development and validation of new Patient Reported Outcomes measures as appropriate for inclusion across clinical trials, registries, and prospective real world studies.
Identify opportunities to partner with Oncology BU external customers to conduct HEOR projects in support of asset strategies.
Lead or assist other team members in the timely development of launch and post launch deliverables including global value dossiers (GVDs), evidence blueprints, economic models, and innovative tools to successfully support global launch and post-launch reimbursement and access requirements in conjunction with the regions/countries.
Lead or assist the coordination of input from local country/regional HEOR teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrated evidence strategy to support global market access needs at time of launch.
Lead the development of appropriate data dissemination plans and communicate evidence generated via publications and conference presentations.
Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.
Collaborate with local health and value affiliates and enable local model adaptations and updates throughout the product life cycle.
Provide strategic guidance and content guidance in reimbursement (re)negotiations for Pfizer products.
Minimum Masters degree (MSc, MPH) in health services research, public health, epidemiology, or health economics with a preferred Doctoral degree (PhD, DrPH, ScD) in health services research, public health, epidemiology, or health economics.
Preferred 3-5 years of experience in health outcomes and related fields, 1-2 of which are as part of health economics and/or outcomes research teams in a pharmaceutical company.
Competence in technical and methodological aspects of registries and observational study design and implementation. Capable of independently managing non-interventional study projects.
Strong methodological skills (study design, data analysis and interpretation) in cancer epidemiology or health services research is required
Knowledge and experience in the Oncology therapeutic area.
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
Excellent oral and written English communication skills required
Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
Ability to influence key members of medical and commercial teams constructively and without conflict.
Skilled in functioning within a matrix organization where managing through influence is required.
Exhibit strong collaboration skills and ability to engage across multiple functions and business units, manage consensus at various levels and cultivate strategic internal relationships across a highly matrixed organization.
Organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize & address/resolve
Change oriented, comfortable responding to unexpected demands with tight timelines; team player.
Estimated 20% travel will be required, including international travel.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
Other Job Details:
- Last Date to Apply for Job: March 26, 2018
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.